385 related articles for article (PubMed ID: 17669543)
1. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
Tarragó-Trani MT; Storrie B
Adv Drug Deliv Rev; 2007 Aug; 59(8):782-97. PubMed ID: 17669543
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum.
Girod A; Storrie B; Simpson JC; Johannes L; Goud B; Roberts LM; Lord JM; Nilsson T; Pepperkok R
Nat Cell Biol; 1999 Nov; 1(7):423-30. PubMed ID: 10559986
[TBL] [Abstract][Full Text] [Related]
3. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin.
Sandvig K; van Deurs B
FEBS Lett; 2002 Oct; 529(1):49-53. PubMed ID: 12354612
[TBL] [Abstract][Full Text] [Related]
4. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
McKenzie J; Johannes L; Taguchi T; Sheff D
FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
[TBL] [Abstract][Full Text] [Related]
5. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.
Sandvig K; Ryd M; Garred O; Schweda E; Holm PK; van Deurs B
J Cell Biol; 1994 Jul; 126(1):53-64. PubMed ID: 8027186
[TBL] [Abstract][Full Text] [Related]
6. "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
Medina-Kauwe LK
Adv Drug Deliv Rev; 2007 Aug; 59(8):798-809. PubMed ID: 17707545
[TBL] [Abstract][Full Text] [Related]
7. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.
Sandvig K; Garred O; Prydz K; Kozlov JV; Hansen SH; van Deurs B
Nature; 1992 Aug; 358(6386):510-2. PubMed ID: 1641040
[TBL] [Abstract][Full Text] [Related]
8. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.
Falguières T; Mallard F; Baron C; Hanau D; Lingwood C; Goud B; Salamero J; Johannes L
Mol Biol Cell; 2001 Aug; 12(8):2453-68. PubMed ID: 11514628
[TBL] [Abstract][Full Text] [Related]
9. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport.
Mallard F; Antony C; Tenza D; Salamero J; Goud B; Johannes L
J Cell Biol; 1998 Nov; 143(4):973-90. PubMed ID: 9817755
[TBL] [Abstract][Full Text] [Related]
10. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
Luginbuehl V; Meier N; Kovar K; Rohrer J
Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805
[TBL] [Abstract][Full Text] [Related]
11. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
[TBL] [Abstract][Full Text] [Related]
12. Retrograde transport of protein toxins through the Golgi apparatus.
Sandvig K; Skotland T; van Deurs B; Klokk TI
Histochem Cell Biol; 2013 Sep; 140(3):317-26. PubMed ID: 23765164
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis and intracellular sorting of ricin and Shiga toxin.
Sandvig K; van Deurs B
FEBS Lett; 1994 Jun; 346(1):99-102. PubMed ID: 8206167
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis and retrograde transport of Shiga toxin.
Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
[TBL] [Abstract][Full Text] [Related]
15. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
Raa H; Grimmer S; Schwudke D; Bergan J; Wälchli S; Skotland T; Shevchenko A; Sandvig K
Traffic; 2009 Jul; 10(7):868-82. PubMed ID: 19453975
[TBL] [Abstract][Full Text] [Related]
16. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin.
Johannes L; Tenza D; Antony C; Goud B
J Biol Chem; 1997 Aug; 272(31):19554-61. PubMed ID: 9235960
[TBL] [Abstract][Full Text] [Related]
17. Pathways followed by ricin and Shiga toxin into cells.
Sandvig K; Grimmer S; Lauvrak SU; Torgersen ML; Skretting G; van Deurs B; Iversen TG
Histochem Cell Biol; 2002 Feb; 117(2):131-41. PubMed ID: 11935289
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the transport of ricin to the cytoplasm is independent of both Rab6A and COPI.
Chen A; AbuJarour RJ; Draper RK
J Cell Sci; 2003 Sep; 116(Pt 17):3503-10. PubMed ID: 12865434
[TBL] [Abstract][Full Text] [Related]
19. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin.
Sandvig K; van Deurs B
Physiol Rev; 1996 Oct; 76(4):949-66. PubMed ID: 8874490
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rab22a hampers the transport between endosomes and the Golgi apparatus.
Mesa R; Magadán J; Barbieri A; López C; Stahl PD; Mayorga LS
Exp Cell Res; 2005 Apr; 304(2):339-53. PubMed ID: 15748882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
